These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13151630)

  • 1. [Effect of triphenylmethane dyes on Trypanosoma cruzi in vitro; use of gentian violet in prevention of transmission of Chagas disease by blood transfusion].
    NUSSENZWEIG V; SONNTAG R; BIANCALANA A; DE FREITAS JL; AMATO NETO V; KLOETZEL J
    Hospital (Rio J); 1953 Dec; 44(6):731-44. PubMed ID: 13151630
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent data on the use of gentian violet in prevention of the transmission of Chagas'disease by blood transfusion].
    NUSSENZWEIG V; AMATO NETO V; MELLONE O
    Hospital (Rio J); 1959 Feb; 55(2):183-8. PubMed ID: 13640534
    [No Abstract]   [Full Text] [Related]  

  • 3. A strategy for the prevention of the transmission of Chagas' disease during blood transfusion.
    Hammond DJ; Croft SL; Hogg J; Gutteridge WE
    Acta Trop; 1986 Dec; 43(4):367-78. PubMed ID: 2882664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the efficiency of gentian violet in the prevention of the transmission of Chagas'disease in blood banks: investigation of a volunteer, a receiver of dye-treated blood from an acute case.
    AMATO NETO V; MELLONE O
    Hospital (Rio J); 1959 Mar; 55(3):343-6. PubMed ID: 13640546
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of physical and chemical agents of Trypanosoma cruzi in vitro].
    NUSSENZWEIG V; NUSSENZWEIG RS; DE FREITAS JL; AMATO NETO V; BIANCALANA A; KLOETZEL J
    Hospital (Rio J); 1954 May; 45(5):589-99. PubMed ID: 13183561
    [No Abstract]   [Full Text] [Related]  

  • 6. [Post-transfusion Chagas' disease].
    Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(3):135-7. PubMed ID: 3150608
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the eventual activity of cyclosporin A in preventing the transmission, by blood transfusion, of Trypanosoma cruzi infection].
    Amato Neto V; Pasternak J; de Souza ER; Costa AM; Matsubara L
    Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(4):195-6. PubMed ID: 9567370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light.
    Ramirez LE; Lages-Silva E; Pianetti GM; Rabelo RM; Bordin JO; Moraes-Souza H
    Transfusion; 1995 Mar; 35(3):226-30. PubMed ID: 7878715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The danger of transmission of Chagas' disease by blood transfusion].
    ROSENBAUM MB; ALVAREZ AJ; CERISOLA JA
    Prensa Med Argent; 1957 Nov; 44(45):3305-8. PubMed ID: 13542485
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of Chagas' disease resulting from blood transfusion by treatment of blood: toxicity and mode of action of gentian violet.
    Docampo R; Moreno SN; Gadelha FR; de Souza W; Cruz FS
    Biomed Environ Sci; 1988 Dec; 1(4):406-13. PubMed ID: 3151757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chagas' disease and blood transfusion: trypanocidal activity of maprotiline hydrochloride and gentian violet].
    Celentano AM; González Cappa SM
    Medicina (B Aires); 1988; 48(3):265-8. PubMed ID: 3150028
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfusion-acquired Trypanosoma cruzi infection.
    Young C; Losikoff P; Chawla A; Glasser L; Forman E
    Transfusion; 2007 Mar; 47(3):540-4. PubMed ID: 17319837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian Blood Services to screen for Chagas disease.
    Comeau P
    CMAJ; 2007 Jul; 177(3):242. PubMed ID: 17664439
    [No Abstract]   [Full Text] [Related]  

  • 14. High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina.
    Sánchez Negrette O; Mora MC; Basombrío MA
    Pediatrics; 2005 Jun; 115(6):e668-72. PubMed ID: 15930194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas' disease.
    Rassi A; Dias JC; Marin-Neto JA; Rassi A
    Heart; 2009 Apr; 95(7):524-34. PubMed ID: 19131444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusional chagas disease: parasitological and serological monitoring of an infected recipient and blood donor.
    Flores-Chávez M; Fernández B; Puente S; Torres P; Rodríguez M; Monedero C; Cruz I; Gárate T; Cañavate C
    Clin Infect Dis; 2008 Mar; 46(5):e44-7. PubMed ID: 18257698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chagas' disease: lessons from routine donation testing.
    Castro E
    Transfus Med; 2009 Feb; 19(1):16-23. PubMed ID: 19302451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of gentian violet on Trypanosoma cruzi in vitro; importance in the sterilization of blood for transfusion].
    NUSSENZWEIG V; BIANCALANA A; AMATO NETO V; SONNTAG R; DE FREITAS JP; KLOETZEL J
    Rev Paul Med; 1953 Jan; 42(1):57-8. PubMed ID: 13075109
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood donor screening for chagas disease--United States, 2006-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):141-3. PubMed ID: 17318113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and mode of action of gentian violet.
    Moreno SN
    Mem Inst Oswaldo Cruz; 1988 Nov; 83 Suppl 1():308-20. PubMed ID: 3150994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.